Pharma News

Get the latest news from world and India’s leading pharmaceutical companies Pharma Industry, pharmaceutical marketing, generic drugs, and Complete news for Pharmacy and Life Sciences professionals.

  • The Cabinet of the Union has approved a Memorandum of Understanding between India and Australia on cooperation in the field of communicable diseases and mental health. The MoU will involve cooperation through joint initiatives in the health sector and strengthen bilateral ties between India and Australia.

  • Lucknow Chapter  of  the Indian Medical Association (IMA) has written to the World Health Organization (WHO) requesting the addition of the words "spiritual well-being" in the official definition of "health". In a letter to Dr. Margaret Chan, WHO's Director General, the association highlighted the theme of World Health Day-2017 - Depression Let's Talk - as a reason for the demand.

    "The current definition of health states that it is a complete state of physical, mental and social well-being and not merely the absence of disease or infirmity. But the theme of World Health Day this year being Depression, it is clear that it also belongs to Inner Wellness, "said Dr. PK Gupta, President, IMA Lucknow.

    The letter claims that such an addition to the official definition will raise awareness of inner well-being through spiritual means such as yoga, meditation, prayer and others. World Health Day is celebrated every year around the world on 7 April.

    << Back to Pharma News


    Subscribe to PharmaTutor News Alerts by Email

  • A group of major national pharmaceutical companies, IPA has hit the government on the issue of drug price control, wondering if the country was following the rule of law for the sector. In a letter written to Niti Aayog's vice president Arvind Panagariya, the IPA said that the last two years have been disturbing for the national pharmaceutical industry due to the "arbitrary and imaginative" implementation of drug policy Prices of medicines.

  • The government proposed a new set of rules for dealing with right to information requests, complaints and appeals and asked for suggestions to the public before April 15. The proposed rules to replace the 2012 ITR rules have been placed by the Personnel and Training Department (DoPT) on its website for public comment.

  • Roche announced the CE-IVD launch of the cobas® Liat® PCR System with four assays including first 20 minute real-time PCR nucleic acid test to detect Clostridium difficile (C. diff). Countries accepting CE mark are the first to receive access to the cobas® Cdiff test, which detects C. diff in stool specimens from symptomatic patients1 and provides rapid and definitive results in under 20 minutes. Timely and accurate diagnosis of this infection is important because it can quickly become life threatening, especially to high-risk patients such as the elderly, immuno-compromised and those undergoing antibiotic treatment.

  • Cipla Ltd, a global pharmaceutical company, announced that it has received final approval for its Abbreviated New Drug Application (ANDA) for Abacavir and Lamivudine Tablets USP, 600 mg/300 mg, from the United States Food and Drug Administration (USFDA).

  • U.S. Food and Drug Administration approved Ocrevus (ocrelizumab) to treat adult patients with relapsing forms of multiple sclerosis (MS) and primary progressive multiple sclerosis (PPMS). This is the first drug approved by the FDA for PPMS. Ocrevus is an intravenous infusion given by a health care professional.

Subscribe to Pharma News